| Author and year of the study |
Setting |
Population |
Number of Participants |
Duration of Trial |
Mean Age of Participants |
Duration of Diabetes |
Gender Distribution |
| Aso Y et al., 2017 [21] |
Single-Center Study |
Japan |
45 participants [33 in insulin degludec group and 12 in glargine group] |
24 weeks |
64.0±13.6 in insulin degludec and 64.7±15.7 in insulin glargine |
10 years in degludec and 13 years in insulin glargine |
Female participants 55% |
| Kawaguchi Yet al., 2019 [22] |
Single-Center Study |
Japan |
30 patients [15 patients in each group] |
6 months |
69.5 ± 11.3 years |
18.3 ± 11.3 years |
Male participants (60%) |
| Onishi Y et al., 2013 [23] |
A Multi-center Study |
Hong Kong, Japan, Malaysia, South Korea, Taiwan, and Thailand |
435 participants [289 in insulin degludec group and 146 in glargine group] |
26 weeks |
58.6 years |
11.6 Years |
Male participants (53.56%) |
| Yamabe M et al., 2019 [24] |
Single-Center Study |
Japan |
24 participants [12 in each group] |
5 months |
70.7 ± 7.6 (years) |
14.0 ± 9.3 (years) |
Male (50%) |
